Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets - New analysis from Frost & Sullivan, Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets, estimates this to reach $4,273.6 million in 2013
Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets

 

PRZOOM - /newswire/ - Palo Alto, CA, United States, 2006/12/12 - New analysis from Frost & Sullivan, Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets, estimates this to reach $4,273.6 million in 2013.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

As pharmaceutical manufacturers face tighter margins and a host of regulatory and validation issues that are increasing the need to produce drugs at lower costs and at a faster pace, they are likely to turn to automation and software vendors to help them achieve operational efficiency in drug production.

New analysis from Frost & Sullivan, Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets, reveals that the market earned revenues of $2,729.5 million in 2006 and estimates this to reach $4,273.6 million in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of automation and software solutions in the global pharmaceutical markets, send an e-mail to Tori Foster, Corporate Communications, at tori.foster[.]frost.com with your full name, company name, title, telephone number, fax number, and e-mail address. Upon receipt of the above information, an overview will be sent to you by e-mail.

With strict regulatory approvals, manufacturers are finding it increasingly difficult to introduce new drugs in the market. This has greatly influenced the number of drugs entering the market. Hence, there is an emerging need to implement lean and flexible concepts to reduce wastage and bring drugs faster to the market.

“The gradual exit of blockbuster drugs and the introduction of generic ones have increased the pressure on profit margins, compelling manufacturers to produce specialized potent drugs that are difficult to replicate and need to be produced in smaller quantities,” notes Frost & Sullivan Research Analyst Sanjeev R. Sridharan. “As this necessitates the production of multiple products on the same equipment, companies are increasingly employing automation and software solutions.”

Process analytical technology (PAT) is encouraging pharmaceutical manufacturers to adopt innovative technologies without fearing validation risks and production delays, thereby fuelling demand for automation and software solutions. The revised 21 Code of Federal Regulations (CFR) Part 11 regulation stipulated by the Food and Drug Administration (FDA) requires pharmaceutical manufacturers to provide greater production transparency through audit trails and access control functions. It also puts forth the criterion that electronic records and signatures are equivalent to paper records and handwritten documents in manufacturing processes. Therefore, companies are compelled to develop sophisticated means of electronic validation and batch recording.

However, as the pharmaceutical industry is highly regulated, the FDA audits and approves every new process addition. The risk of non-compliance is too high for pharmaceutical companies and thus, massive investments on automation and software solutions are relatively lesser.

“The key success factor for automation companies is to establish long-term partnership with pharmaceutical customers,” says Sanjeev. “Even as pharmaceutical customers look for standardization, automation companies need to grow aggressively with their customers as they expand globally.”

The relationship starts from educating and generating awareness among customers. After selecting specific pharmaceutical engagement opportunities, automation vendors need to build critical momentum and achieve a dominant business differentiator. Long-term partnerships could be profitable to the pharmaceutical industry as well as automation vendors.

The Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets is part of the Factory Automation subscription, which also includes research services in the following markets: Automation and Software Solutions in World Food and Beverage, World Human Machine Interface and Software and World Distributed Control Systems. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews are available to the press.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership service, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Strategic Analysis of the Automation and Software Solutions in the World Pharmaceutical Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Tori Foster 
1.210.477.8448 tori.foster[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com

Visit  NAKIVO, Inc.







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today